Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
暂无分享,去创建一个
M. Gasco | O. Garrone | G. Bertelli | M. Merlano | E. Russi | G. Di Costanzo | C. Granetto | G. Numico | I. Colantonio | M. Occelli | E. Fea | A. Heouaine
[1] Miklos Pless,et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Perry,et al. Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Ratain,et al. Weekly, high‐dose paclitaxel in advanced lung carcinoma , 2003, Cancer.
[4] V. Alberola,et al. Weekly paclitaxel in the treatment of metastatic and/or recurrent non-small cell lung cancer. , 2002, Critical reviews in oncology/hematology.
[5] S. Urien,et al. Weekly administration of paclitaxel: theoretical and clinical basis. , 2002, Critical reviews in oncology/hematology.
[6] V. Carañana,et al. Low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer: a phase II study. , 2002, Japanese journal of clinical oncology.
[7] W. Fiedler,et al. Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer. , 2002, Lung cancer.
[8] G. Koumakis,et al. Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial. , 2002, Lung cancer.
[9] D. Gandara,et al. Premedication Strategy for Weekly Paclitaxel , 2002, Cancer investigation.
[10] A. Chang,et al. Weekly paclitaxel in advanced non-small cell lung cancer. , 2001, Seminars in oncology.
[11] N. Malamos,et al. Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. , 2001, European journal of cancer.
[12] G. Giaccone,et al. Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Ranson,et al. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[14] R. Stephens,et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome , 2000, British Journal of Cancer.
[15] E. Eisenhauer,et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Dancey,et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] K. Roszkowski,et al. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). , 2000, Lung cancer.
[18] G. Luporini,et al. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. , 1999, Journal of the National Cancer Institute.
[19] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[20] M. Socinski,et al. Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial. , 1999, Cancer investigation.
[21] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .